Open AccessPrimary prevention of atrial fibrillation in patients with metabolic syndrome: correction of modifiable risk factors
Author(s) -
А. И. Олесин,
И. В. Константинова
Publication year - 2021
Publication title -
fundamentalʹnaâ i kliničeskaâ medicina
Language(s) - English
Resource type - Journals
eISSN - 2542-0941
pISSN - 2500-0764
DOI - 10.23946/2500-0764-2020-6-2-103-115
Subject(s) - atrial fibrillation , medicine , metabolic syndrome , heart failure , obesity , stroke (engine) , myocardial infarction , cardiology , intensive care medicine , mechanical engineering , engineering
Currently, around 34 million people worldwide suffer from atrial fibrillation (AF), with the number projected to double by 2060. Despite the treatment of AF has been significantly improved during the recent years, AF is still associated with an increased risk of severe complications such as systemic thromboembolism, progression of heart failure, stroke, and myocardial infarction. Due to a high risk of disability and mortality, AF represent a major socioeconomic problem for the healthcare in most countries, also because of related financial costs. Obesity, most often represented by metabolic syndrome, is widely recognized as an epidemic of the XXI century. Here we review the features of AF development in patients with metabolic syndrome, suggesting novel avenues for the primary prevention of AF.